Invention Grant
- Patent Title: Means and methods for treating HBV
-
Application No.: US16069268Application Date: 2017-01-12
-
Publication No.: US10912827B2Publication Date: 2021-02-09
- Inventor: Ulrike Protzer , Tanja Bauer , Anna Kosinska , Martin Mueck-Haeusl
- Applicant: HELMHOLTZ ZENTRUM MÜNCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
- Applicant Address: DE Neuherberg
- Assignee: HELMHOLTZ ZENTRUM MÜNCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
- Current Assignee: HELMHOLTZ ZENTRUM MÜNCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
- Current Assignee Address: DE Neuherberg
- Agency: Riverside Law LLP
- Priority: LU92942 20160112
- International Application: PCT/EP2017/050553 WO 20170112
- International Announcement: WO2017/121791 WO 20170720
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/29 ; C12N15/86 ; C12N15/113 ; A61P31/20 ; A61K39/00
Abstract:
The present invention relates to an improved recombinant vaccination vector for the treatment or vaccination against hepatitis B virus (HBV) as well as pharmaceutical compositions or vaccines comprising said recombinant vaccination vector. The present invention also relates to a recombinant vaccination vector for use in a method of vaccination against HBV, as well as kits comprising a vaccine comprising the recombinant vaccination vector.
Public/Granted literature
- US20190030158A1 MEANS AND METHODS FOR TREATING HBV Public/Granted day:2019-01-31
Information query
